SELLAS Life Sciences Group(DE:RXK3)
€12.55-0.85 (-6.34%)
DE:RXK3
SELLAS Life Sciences Group financials statements
€12.55
At close:-0.85 (-6.34%)
SELLAS Life Sciences Group (RXK3) Income Statement
2 Followers
SELLAS Life Sciences Group Income Statement
Last quarter (Q3 2026), SELLAS Life Sciences Group's total revenue was $0.00. In Q3, SELLAS Life Sciences Group's net income was $-10.09M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 1.00M | $ 7.60M | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 900.00K | $ 7.40M | |
| $ 28.27M | $ 31.51M | $ 37.87M | $ 42.85M | $ 32.69M | |
| Depreciation and Amortization | $ 0.00 | $ 31.51M | $ 37.87M | $ 457.00K | $ 1.27M |
| $ -26.86M | $ 632.00K | $ 529.00K | $ -31.49M | $ -18.32M | |
| $ -28.27M | $ -31.51M | $ -37.87M | $ -41.95M | $ -25.29M | |
| $ 1.41M | $ 632.00K | $ 529.00K | $ 649.00K | $ 4.36M | |
| $ -26.86M | $ -30.88M | $ -37.34M | $ -41.30M | $ -20.94M | |
| $ -26.86M | $ -30.88M | $ -37.34M | $ -41.30M | $ -20.70M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.25 | $ -0.50 | $ -1.34 | $ -2.13 | $ -1.34 |
| Diluted EPS | $ -0.25 | $ -0.50 | $ -1.34 | $ -2.13 | $ -1.34 |
| Weighted Average Shares Outstanding | 109.05M | 61.20M | 27.78M | 19.39M | 15.48M |
| Weighted Average Shares Outstanding (Diluted) | 109.05M | 61.20M | 27.78M | 19.40M | 15.48M |
Currency in USD

